Virtual Medicinal Product (VMP) - Ripretinib 50mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Ripretinib 50mg tablets Start Date 14-09-2022 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L01EX19
SNOMED Codes
Code Start Date End Date
41066211000001106 14-09-2022

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Ripretinib Based on Ingredient Substance 50 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
90 tablet